Advanced Filters
noise

Asthma Clinical Trials

A listing of Asthma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 347 clinical trials
E Eva Fiorenzo, BMBS

Non-Eosinophilic Biological Effects of IL-5

This study aims to investigate the role of IL-5 in suppressing anti-viral immune responses in bronchial epithelial cells (BECs) and in peripheral blood mononuclear cells (PBMCs) from 5 people with asthma.

18 years of age All Phase N/A
J Janelle Grogan

Comparison of Microglial Activation in Severe Asthma and Healthy Controls

The goal of this clinical trial is to learn about how asthma influences brain function. The main questions it aims to answer are: How airway inflammation in asthma affects the brain; and, Whether airway inflammation in asthma is related to symptoms of depression and anxiety Over the course of 3 …

18 - 75 years of age All Phase N/A
A Aydan Aslı Aksel Uylar

Evaluation of Cardiopulmonary Parameters in Individuals With Asthma

The aim of the study compare the cardiopulmonary parameters of individuals with asthma with healthy subjects.

18 - 65 years of age All Phase N/A

Fasenra Pediatric Japan Post-Marketing Study(PMS)

The purpose of the investigation is to confirm the followings under the post-marketing actual use of Fasenra® Subcutaneous Injection 30 mg / 10mg Syringe (hereinafter referred to as Fasenra). Development of unexpected related AEs* To grasp development of related AEs* in the real-world post-marketing setting. Effectiveness (pulmonary function and asthma …

years of age All Phase N/A
J Jun-Tao Feng, MD

The Association of Transgelin-2, Metallothionein-2 and Ezrin With Asthma

Asthma is one of the most common chronic respiratory diseases. Previous study found a series of differentially expressed genes and proteins (transgelin-2, metallothionein-2, ezrin) in asthmatic rat. The aim of the study is to investigate the changes and associations of these gene with asthma in human.

14 - 75 years of age All Phase N/A
N Nia Moore

Protocol CAUSE-03 / CHEETAH

This is a one-year longitudinal, observational study of 250 urban children and adolescents with asthma and 60 without asthma, ages 6-17 years old. Participants with asthma will require daily controller therapy with inhaled corticosteroids ICS (at least Step 2 therapy). Those without asthma cannot have used asthma medications in the …

6 - 17 years of age All Phase N/A

A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population

A Translational Study to Describe Asthma Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes associated with Differential Outcomes that may Support Future Development of Personalised Treatment Strategies in Chinese Population

18 - 75 years of age All Phase N/A
J Judit Varkonyi-Sepp, Chief Investigator

LIving BEtteR With asThma - Intervention Development Study

Approximately 330 million people in the world are living with asthma and 3-10% of them has difficult asthma that is challenging to control even with maximum doses of pharmacological treatment. In the last five years our multidisciplinary team has shown the clinical benefits of a short-term structured exercise programme for …

18 years of age All Phase N/A

Mepolizumab and Physical Activity in Severe Asthma

Severe asthma is a debilitating condition associated with frequent symptoms, life-threatening exacerbations and corticosteroid side-effects. Exercise limitation due to exercise-induced bronchoconstriction, dynamic lung hyperinflation and comorbidity may be a strong determinant of the disease burden. Mepolizumab is a monoclonal anti-interleukin-5 (IL-5) antibody that reduces the rate of severe exacerbations, asthma …

18 - 75 years of age All Phase N/A
j jonas A Baekdal, MD

The Effect of Anti-IL17 on Airway Hyperresponsiveness and Resistance

This observational longitudinal cohort study aims to assess the effect of monoclonal antibodies targeting interleukin 17 (anti-IL-17) on airway hyperreactivity and airway resistance. The study involves adult participants suffering from dermatological or rheumatological illness, who are planning to start treatment with monoclonal antibodies targeting interleukin 17 as a part of …

18 years of age All Phase N/A

Simplify language using AI